Sp296
ACUTE ON CHRONIC LIVER FAILURE AND THE MANAGEMENT OF CRITICALLY ILL PATIENTS WITH CIRRHOSIS + Q&A
Date
May 18, 2024
Explore related products in the following collection:
Presenter
Baylor University Medical Center
Tracks
Related Products
PAAM FOR HEPATOCELLULAR CARCINOMA RISK STRATIFICATION IN PATIENTS WITH CIRRHOSIS: MULTICENTER PHASE 3 BIOMARKER VALIDATION STUDIES IN THE U.S.
BACKGROUND: With the recent increase in metabolic liver diseases and viral hepatitis on anti-viral agents, risk stratification biomarkers are urgently needed to identify cirrhosis patients who should be prioritized for hepatocellular carcinoma (HCC) screening for early detection…
